ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QuadLock(TM), its new ...
Please provide your email address to receive an email when new articles are posted on . Isolated ACL reconstruction had a graft failure rate of 10% vs. 4% in ACL plus anterolateral ligament ...
ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug ...